Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Vp Asset Holdings LLC has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 distinct examiners and 2 distinct art units, showing separate examination channels for the available portfolio.
BARSKY, JARED is the busiest examiner, with 1 pending matter. The profile does not identify examiner concentration, so prosecution planning should remain matter-specific. A comparison of claim themes and disclosure support may still help maintain consistency across responses without assuming identical examination treatment.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §102 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RICCI, CRAIG D | 1 | 53.7% | +52.6% |
| BARSKY, JARED | 1 | 50.3% | +22.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257272 | CRYSTALLINE FORM OF A PHENOLIC TRPV1 AGONIST PRODRUG | RICCI, CRAIG D | — |
| 18257273 | PHARMACEUTICAL FORMULATIONS OF A PHENOLIC TRPV1 AGONIST PRODRUG | BARSKY, JARED | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18257272 | CRYSTALLINE FORM OF A PHENOLIC TRPV1 AGONIST PRODRUG | RICCI, CRAIG D | 1611 | §102 | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18257273 | PHARMACEUTICAL FORMULATIONS OF A PHENOLIC TRPV1 AGONIST PRODRUG | BARSKY, JARED | 1628 | §103Other | Final Rejection | — | Pending | Jun 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVp Asset Holdings LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Craig D Ricci has the most, with 1 of Vp Asset Holdings LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
